Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-01-13 @ 7:51 AM
Study NCT ID:
NCT05688332
Status:
UNKNOWN
Last Update Posted:
2023-07-03
First Post:
2022-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients
Sponsor:
University of Zambia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-27
First Submit QC Date:
None
Study First Post Date:
2023-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-28
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL